GLP-1 Friendly? The communication challenge is only just beginning

This is an opinion article written by André Gerson, CEO of GCIMedia Group, addressing the communication challenges associated with GLP-1 category medications such as Ozempic and Wegovy. The title "GLP-1 Friendly?" suggests a reflection on how the industry and communication professionals should position themselves regarding these drugs, which have been experiencing significant market growth. The author appears to warn that, although the category is expanding, the way these medications are communicated about is still in an early phase and faces obstacles that need to be overcome. The opinion expressed in the article reflects the perspective of a media sector leader focused on the health and pharmaceutical industries, indicating that communication around GLP-1 requires particular strategic attention.